Related references
Note: Only part of the references are listed.Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine
Adriana C. Gamboa et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity
Miro E. Raeber et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity
David A. Knorr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
Lelinh Duong et al.
FRONTIERS IN GENETICS (2018)
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?
Bernard Seguin
FRONTIERS IN ONCOLOGY (2017)
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap et al.
LANCET (2016)
Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
Peter Johnson et al.
CLINICAL CANCER RESEARCH (2015)
Comparative Pathology of Canine Soft Tissue Sarcomas: Possible Models of Human Non-rhabdomyosarcoma Soft Tissue Sarcomas
M. Milovancev et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2015)
Naturally Occurring Cancers in Dogs: Insights for Translational Genetics and Medicine
Carlos E. Alvarez
ILAR JOURNAL (2014)
Role of Crosslinking for Agonistic CD40 Monoclonal Antibodies as Immune Therapy of Cancer
Lee P. Richman et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
Connie Jackaman et al.
AGING CELL (2013)
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
G. Ranieri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
A Comparative Review of Canine and Human Rhabdomyosarcoma With Emphasis on Classification and Pathogenesis
B. G. Caserto
VETERINARY PATHOLOGY (2013)
The genomics of selection in dogs and the parallel evolution between dogs and humans
Guo-dong Wang et al.
NATURE COMMUNICATIONS (2013)
Canine tumors: a spontaneous animal model of human carcinogenesis
Salome S. Pinho et al.
TRANSLATIONAL RESEARCH (2012)
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
Ronald P. Gladue et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
CD40-activated B cells contribute to mesothelioma tumor regression
Connie Jackaman et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells
C. Jackaman et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors
Rachael Thomas et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway
Ira Gordon et al.
PLOS MEDICINE (2009)
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
Connie Jackaman et al.
INTERNATIONAL IMMUNOLOGY (2008)
Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
Juliana Hamzah et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas
G Stoica et al.
VETERINARY PATHOLOGY (2004)
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature:: A novel mechanism for IL-21
C Jackaman et al.
JOURNAL OF IMMUNOLOGY (2003)
In vivo cross-presentation of a soluble protein antigen: Kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes
D Nelson et al.
JOURNAL OF IMMUNOLOGY (2000)
Spontaneously occurring tumors of companion animals as models for human cancer
DM Vail et al.
CANCER INVESTIGATION (2000)
Share Paper
